Advanced search
Publication Cover
Journal of Asthma Volume 59, 2022 - Issue 10
Submit an article Journal homepage
413
Views
11
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Cost‑effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma

Jefferson Antonio BuendiaDepartment of Pharmacology and Toxicology, Faculty of Medicine, University of Antioquia, Medellin, ColombiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2404-6612
, PhDORCID Icon,
Diana Guerrero PatiñoDepartment of Pharmacology and Toxicology, Faculty of Medicine, University of Antioquia, Medellin, Colombia
, MSc &
Yamith Eutimio Cossio-GiraldoDepartment of Pharmacology and Toxicology, Faculty of Medicine, University of Antioquia, Medellin, Colombia
, MD
Pages 2016-2023 | Received 10 May 2021, Accepted 19 Sep 2021, Published online: 12 Oct 2021

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Jefferson Antonio Buendía, Diana Guerrero Patiño & Andrés Felipe Zuluaga Salazar. (2024) Cost effectiveness of omalizumab for severe asthma in Colombia. Journal of Asthma 61:4, pages 292-299.
Read now
Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, Emma Behan, M. Sakil Syeed, Ammarin Thakkinstian, David C. Young & Nathorn Chaiyakunapruk. (2023) Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies. Journal of Asthma 60:9, pages 1702-1714.
Read now
Jefferson Antonio Buendía & Diana Guerrero Patiño. (2023) Tiotropium for children and adolescents with severe asthma. Journal of Asthma 60:5, pages 1009-1015.
Read now
Jefferson Antonio Buendía, Carlos E. Rodriguez-Martinez & Monica P. Sossa-Briceño. (2023) Cost utility of vitamin D supplementation in adults with mild to moderate asthma. Journal of Asthma 60:5, pages 951-959.
Read now
Jefferson Antonio Buendía,Diana Guerrero Patiño. (2023) Fluticasone furoate plus vilanterol in patients with moderate persistent asthma: a cost-utility analysis. Journal of Asthma 60:2, pages 377-384.
Read now

Articles from other publishers (6)

Ashna Mehra, Rebecca Grohman, Sohini Shah & Anna Nowak-Węgrzyn. (2023) Food Allergy: Emerging Therapies. Current Treatment Options in Allergy 10:3, pages 319-339.
Crossref
Jefferson Antonio Buendía, Ricardo Hernández-Sarmiento & Jorge Enrique Rojas Medina. (2023) Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income Country. Value in Health Regional Issues 35, pages 1-7.
Crossref
Jefferson A. Buendía & Diana G. Patiño. (2022) Dupilumab in children with moderate‐to‐severe asthma: A cost utility analysis. Pediatric Pulmonology 57:10, pages 2313-2319.
Crossref
Jason R. Burchett, Jordan M. Dailey, Sydney A. Kee, Destiny T. Pryor, Aditya Kotha, Roma A. Kankaria, David B. Straus & John J. Ryan. (2022) Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing. Cells 11:19, pages 3031.
Crossref
Jefferson Antonio Buendía & Diana Guerrero Patiño. (2021) Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma. BMC Pulmonary Medicine 21:1.
Crossref
Jefferson Antonio Buendía & Diana Guerrero Patiño. (2021) Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma. BMC Pulmonary Medicine 21:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.